INHIBITION OF PLATELET INTEGRIN GPIIbIIIa PROLONGS SURVIVAL OF DISCORDANT CARDIAC XENOGRAFTS1,2
SELECTIVE IgM DEPLETION PROLONGS ORGAN SURVIVAL IN AN EX VIVO MODEL OF PIG-TO-HUMAN XENOTRANSPLANTATION1,2
CONDITIONING OF LIVER GRAFTS BY DONOR BOLUS PRETREATMENT WITH EPOPROSTENOL
ISCHEMIC PRECONDITIONING ENHANCES DONOR HEART PRESERVATION1
ALLOANTIBODY AND INTRAGRAFT CELLULAR RESPONSE TO MHC CLASS I-DISPARATE KIDNEY ALLOGRAFTS IN RECIPIENTS TOLERIZED BY DONOR-SPECIFIC TRANSFUSION AND CYCLOSPORINE1
PORCINE ISLET CELLS OF LANGERHANS ARE DESTROYED BY HUMAN COMPLEMENT AND NOT BY ANTIBODY-DEPENDENT CELL-MEDIATED MECHANISMS1
CYTOMEGALOVIRUS ANTIBODY STATUS AND RENAL TRANSPLANTATION: 1987-1994
HALF DOSE OF OKT3 IS EFFICIENT IN TREATMENT OF STEROID-RESISTANT RENAL ALLOGRAFT REJECTION
OUTCOME OF GRAFTS WITH LONG-LASTING DELAYED FUNCTION AFTER RENAL TRANSPLANTATION
RENAL FUNCTION AND GLOMERULAR PERMSELECTIVITY LATE AFTER LIVING RELATED DONOR TRANSPLANTATION1
A RANDOMIZED TRIAL COMPARING SAFETY AND EFFICACY OF OKT3 AND A MONOCLONAL ANTI-INTERLEUKIN-2 RECEPTOR ANTIBODY (BT563) IN THE PREVENTION OF ACUTE REJECTION AFTER HEART TRANSPLANTATION
LIVER DYSFUNCTION IN ALLOGENEIC BONE MARROW TRANSPLANTATION RECIPIENTS
SAFE USE OF HEPATIC ALLOGRAFTS FROM DONORS OLDER THAN 70 YEARS1
COMPARISON OF CONVENTIONAL ORAL CYCLOSPORINE AND CYCLOSPORINE MICROEMULSION FORMULATIONS IN CHILDREN WITH A LIVER TRANSPLANT
ORIGINAL EXTRAHILAR APPROACH FOR HEPATIC PORTAL REVASCULARIZATION AND RELIEF OF EXTRAHEPATIC PORTAL HYPERTENSION RELATED TO LATE PORTAL VEIN THROMBOSIS AFTER PEDIATRIC LIVER TRANSPLANTATION
DOMINANCE OF TISSUE-RESTRICTED CYTOTOXIC T LYMPHOCYTES IN THE RESPONSE TO ALLOGENEIC RENAL EPITHELIAL CELL LINES1
SECRETION OF CTLA4IG BY AN SV40 T ANTIGEN-TRANSFORMED ISLET CELL LINE INHIBITS GRAFT REJECTION AGAINST THE NEOANTIGEN1
DELAYED XENOGRAFT REJECTION IN THE CONCORDANT HAMSTER HEART INTO LEWIS RAT MODEL1
THE INTRAGRAFT CD8+ T CELL RESPONSE IN RENAL ALLOGRAFT REJECTION IN THE MOUSE1,2
REMOVAL OF TERMINAL α-GALACTOSYL RESIDUES FROM XENOGENEIC PORCINE ENDOTHELIAL CELLS
LATE REFLUSH IN CLINICAL RENAL TRANSPLANTATION
INDUCTION OF PERSISTENT ALLOGRAFT TOLERANCE IN THE RAT BY COMBINED TREATMENT WITH ANTI-LEUKOCYTE FUNCTION-ASSOCIATED ANTIGEN-1 AND ANTI-INTERCELLULAR ADHESION MOLECULE-1 MONOCLONAL ANTIBODIES,DONOR-SPECIFIC TRANSFUSION, AND FK506
EFFECT OF GRAPEFRUIT JUICE ON CYCLOSPORINE PHARMACOKINETICS IN RENAL TRANSPLANT PATIENTS1
STATUS OF MICROCHIMERISM IN RECIPIENTS 15 YEARS AFTER LIVING RELATED KIDNEY TRANSPLANTATION
A PROSPECTIVE STUDY ON THE RELIABILITY AND COST EFFECTIVENESS OF PREOPERATIVE ULTRASOUND SCREENING OF THE “MARGINAL” LIVER DONOR1
CONTINUOUS VENOVENOUS HEMOFILTRATION WITH DIALYSIS IN COMBINATION WITH TOTAL HEPATECTOMY AND PORTOCAVAL SHUNTING
ORTHOTOPIC LIVER TRANSPLANTATION FROM A DONOR WITH ABDOMINAL SITUS INVERSUS
PORCINE ISLETS FOR XENOTRANSPLANTATION
SOLUBLE INTERLEUKIN-6 RECEPTORS IN HEMATOLOGY PATIENTS UNDERGOING BONE MARROW TRANSPLANTATION1
THE EFFECT OF LUNG PRESERVATION ON ALVEOLAR SURFACTANT
THE EFFECT OF LUNG PRESERVATION ON ALVEOLAR SURFACTANT (REPLY)
USE OF PERCUTANEOUSLY PLACED CATHETERS FOR VENOVENOUS BYPASS IN ORTHOTOPIC LIVER TRANSPLANTATION
REVERSAL OF THE OKT3-RELATED SHIVERING AND CHEST TIGHTNESS BY INTRAVENOUS MEPERIDINE